Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: Restorative effect of pharmacological intervention

Pharmacological Research

Volumn 103, Issue , 2016, Pages 1-12

  Rossetti, Andrea C ^a   Papp, Mariusz ^b   Gruca, Piotr ^b   Paladini, Maria Serena ^a   Racagni, Giorgio ^a   Riva, Marco A ^a   Molteni, Raffaella ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepressant; Chronic mild stress; Cytokines; Differential susceptibility; Microglia activation; Sucrose intake

Indexed keywords

AGOMELATINE; CD11B ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; IMIPRAMINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LURASIDONE; ACETAMIDE DERIVATIVE; ANTIDEPRESSANT AGENT; CHEMOKINE RECEPTOR; CX3CL1 PROTEIN, RAT; CX3CR1 PROTEIN, RAT; IL1B PROTEIN, RAT; INTERLEUKIN-6, MOUSE; MESSENGER RNA; NEUROLEPTIC AGENT; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC MILD STRESS; CHRONIC STRESS; CONTROLLED STUDY; CORRELATION ANALYSIS; DORSAL HIPPOCAMPUS; GENE EXPRESSION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SUGAR INTAKE; UPREGULATION; VENTRAL HIPPOCAMPUS; ANIMAL; BRAIN; GENE EXPRESSION PROFILING; GENETICS; HIPPOCAMPUS; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; WISTAR RAT;

ACETAMIDES; ANHEDONIA; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIGENS, CD11B; ANTIPSYCHOTIC AGENTS; BRAIN; CHEMOKINE CX3CL1; GENE EXPRESSION PROFILING; HIPPOCAMPUS; IMIPRAMINE; INTERLEUKIN-1BETA; INTERLEUKIN-6; LURASIDONE HYDROCHLORIDE; MALE; PREFRONTAL CORTEX; RATS, WISTAR; RECEPTORS, CHEMOKINE; RNA, MESSENGER; STRESS, PHYSIOLOGICAL; TRANSFORMING GROWTH FACTOR BETA;

EID: 84947432390     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.10.022     Document Type: Article

References (64)

1. R.C. Kessler, S. Aguilar-Gaxiola, J. Alonso, S. Chatterji, S. Lee, J. Ormel, T.B. Ustun, and P.S. Wang The global burden of mental disorders: an update from the who world mental health (wmh) surveys Epidemiol. Psychiatry Soc. 18 2009 23 33
2. M.F. Juruena Early-life stress and hpa axis trigger recurrent adulthood depression Epilepsy Behav. 38C 2014 148 159
3. T. Klengel, and E.B. Binder Gene-environment interactions in major depressive disorder Can. J. Psychiatry 58 2013 76 83
4. B.G. Shapero, S.K. Black, R.T. Liu, J. Klugman, R.E. Bender, L.Y. Abramson, and L.B. Alloy Stressful life events and depression symptoms: the effect of childhood emotional abuse on stress reactivity J. Clin. Psychol. 70 2014 209 223
5. A. Feder, E.J. Nestler, and D.S. Charney Psychobiology and molecular genetics of resilience Nat. Rev. Neurosci. 10 2009 446 457
6. T.B. Franklin, B.J. Saab, and I.M. Mansuy Neural mechanisms of stress resilience and vulnerability Neuron 75 2012 747 761
7. R. Dantzer, J.C. O'Connor, G.G. Freund, R.W. Johnson, and K.W. Kelley From inflammation to sickness and depression: when the immune system subjugates the brain Nat. Rev. Neurosci. 9 2008 46 56
8. A.H. Miller, V. Maletic, and C.L. Raison Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression Biol. Psychiatry 65 2009 732 741
9. B. Leonard, and M. Maes Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression Neurosci. Biobehav. Rev. 36 2012 764 785
10. Y. Dowlati, N. Herrmann, W. Swardfager, H. Liu, L. Sham, E.K. Reim, and K.L. Lanctot A meta-analysis of cytokines in major depression Biol. Psychiatry 67 2010 446 457
11. T. Benton, J. Staab, and D.L. Evans Medical co-morbidity in depressive disorders Ann. Clin. Psychiatry 19 2007 289 303
12. M. Udina, P. Castellvi, J. Moreno-Espana, R. Navines, M. Valdes, X. Forns, K. Langohr, R. Sola, E. Vieta, and R. Martin-Santos Interferon-induced depression in chronic hepatitis c: a systematic review and meta-analysis J. Clin. Psychiatry 73 2012 1128 1138
13. A. Danese, T.E. Moffitt, C.M. Pariante, A. Ambler, R. Poulton, and A. Caspi Elevated inflammation levels in depressed adults with a history of childhood maltreatment Arch. Gen. Psychiatry 65 2008 409 415
14. A. Danese, C.M. Pariante, A. Caspi, A. Taylor, and R. Poulton Childhood maltreatment predicts adult inflammation in a life-course study Proc. Natl. Acad. Sci. U. S. A. 104 2007 1319 1324
15. T.W. Pace, T.C. Mletzko, O. Alagbe, D.L. Musselman, C.B. Nemeroff, A.H. Miller, and C.M. Heim Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress Am. J. Psychiatry 163 2006 1630 1633
16. Y. Couch, D.C. Anthony, O. Dolgov, A. Revischin, B. Festoff, A.I. Santos, H.W. Steinbusch, and T. Strekalova Microglial activation, increased tnf and sert expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia Brain Behav. Immun. 29 2013 136 146
17. J. Gibb, S. Hayley, M.O. Poulter, and H. Anisman Effects of stressors and immune activating agents on peripheral and central cytokines in mouse strains that differ in stressor responsivity Brain Behav. Immun. 25 2011 468 482
18. M. Girotti, J.J. Donegan, and D.A. Morilak Chronic intermittent cold stress sensitizes neuro-immune reactivity in the rat brain Psychoneuroendocrinology 36 2011 1164 1174
19. Z. You, C. Luo, W. Zhang, Y. Chen, J. He, Q. Zhao, R. Zuo, and Y. Wu Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: involvement in depression Behav. Brain Res. 225 2011 135 141
20. A. Bergstrom, M.N. Jayatissa, A. Mork, and O. Wiborg Stress sensitivity and resilience in the chronic mild stress rat model of depression; an in situ hybridization study Brain Res. 1196 2008 41 52
21. M.N. Hill, K.G. Hellemans, P. Verma, B.B. Gorzalka, and J. Weinberg Neurobiology of chronic mild stress: parallels to major depression Neurosci. Biobehav. Rev. 36 2012 2085 2117
22. B. Pochwat, B. Szewczyk, M. Sowa-Kucma, A. Siwek, U. Doboszewska, W. Piekoszewski, P. Gruca, M. Papp, and G. Nowak Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the nmda receptor subunits Int. J. Neuropsychopharmacol. 17 2014 393 405
23. D. Zurawek, A. Faron-Gorecka, M. Kusmider, M. Kolasa, P. Gruca, M. Papp, and M. Dziedzicka-Wasylewska Mesolimbic dopamine d(2) receptor plasticity contributes to stress resilience in rats subjected to chronic mild stress Psychopharmacology (Berl.) 227 2013 583 593
24. P. Willner Chronic mild stress (cms) revisited: consistency and behavioural-neurobiological concordance in the effects of cms Neuropsychobiology 52 2005 90 110
25. B. Vollmayr, D. Bachteler, V. Vengeliene, P. Gass, R. Spanagel, and F. Henn Rats with congenital learned helplessness respond less to sucrose but show no deficits in activity or learning Behav. Brain Res. 150 2004 217 221
26. R.S. Duman, and G.K. Aghajanian Synaptic dysfunction in depression: potential therapeutic targets Science 338 2012 68 72
27. V. Krishnan, and E.J. Nestler Linking molecules to mood: new insight into the biology of depression Am. J. Psychiatry 167 2010 1305 1320
28. M. Papp Models of affective illness: chronic mild stress in the rat Curr. Protoc. Pharmacol. 2012 Chapter 5: Unit 5 9
29. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 3rd ed. 1996 Academic Press New York
30. M. Papp, P. Gruca, P.A. Boyer, and E. Mocaer Effect of agomelatine in the chronic mild stress model of depression in the rat Neuropsychopharmacology 28 2003 694 703
31. T. Ishiyama, K. Tokuda, T. Ishibashi, A. Ito, S. Toma, and Y. Ohno Lurasidone (sm-13496), a novel atypical antipsychotic drug, reverses mk-801-induced impairment of learning and memory in the rat passive-avoidance test Eur. J. Pharmacol. 572 2007 160 170
32. F.I. Tarazi, and M.A. Riva The preclinical profile of lurasidone: clinical relevance for the treatment of schizophrenia Expert Opin. Drug Discov. 8 2013 1297 1307
33. F. Macchi, J.R. Homberg, F. Calabrese, C. Zecchillo, G. Racagni, M.A. Riva, and R. Molteni Altered inflammatory responsiveness in serotonin transporter mutant rats J. Neuroinflammation 10 2013 116
34. M. Papp, E. Moryl, and P. Willner Pharmacological validation of the chronic mild stress model of depression Eur. J. Pharmacol. 296 1996 129 136
35. K. Saijo, and C.K. Glass Microglial cell origin and phenotypes in health and disease Nat. Rev. Immunol. 11 2011 775 787
36. C. Perego, S. Fumagalli, and M.G. De Simoni Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice J. Neuroinflammation 8 2011 174
37. J.K. Harrison, Y. Jiang, S. Chen, Y. Xia, D. Maciejewski, R.K. McNamara, W.J. Streit, M.N. Salafranca, S. Adhikari, D.A. Thompson, P. Botti, K.B. Bacon, and L. Feng Role for neuronally derived fractalkine in mediating interactions between neurons and cx3cr1-expressing microglia Proc. Natl. Acad. Sci. U. S. A. 95 1998 10896 10901
38. J.W. Koo, and R.S. Duman Il-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress Proc. Natl. Acad. Sci. U. S. A. 105 2008 751 756
39. I. Goshen, T. Kreisel, O. Ben-Menachem-Zidon, T. Licht, J. Weidenfeld, T. Ben-Hur, and R. Yirmiya Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression Mol. Psychiatry 13 2008 717 728
40. S. Chourbaji, A. Urani, I. Inta, C. Sanchis-Segura, C. Brandwein, M. Zink, M. Schwaninger, and P. Gass Il-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors Neurobiol. Dis. 23 2006 587 594
41. T.H. Wu, and C.H. Lin Il-6 mediated alterations on immobile behavior of rats in the forced swim test via erk1/2 activation in specific brain regions Behav. Brain Res. 193 2008 183 191
42. F.R. Walker, M. Nilsson, and K. Jones Acute and chronic stress-induced disturbances of microglial plasticity, phenotype and function Curr. Drug Targets 14 2013 1262 1276
43. K. Biber, H. Neumann, K. Inoue, and H.W. Boddeke Neuronal 'on' and 'off' signals control microglia Trends Neurosci. 30 2007 596 602
44. T. Kreisel, M.G. Frank, T. Licht, R. Reshef, O. Ben-Menachem-Zidon, M.V. Baratta, S.F. Maier, and R. Yirmiya Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis Mol. Psychiatry 19 2014 699 709
45. G. Milior, C. Lecours, L. Samson, K. Bisht, S. Poggini, F. Pagani, C. Deflorio, C. Lauro, S. Alboni, C. Limatola, I. Branchi, M.E. Tremblay, and L. Maggi Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress Brain Behav. Immun. 2015
46. A.K. Clark, D. Gruber-Schoffnegger, R. Drdla-Schutting, K.J. Gerhold, M. Malcangio, and J. Sandkuhler Selective activation of microglia facilitates synaptic strength J. Neurosci. 35 2015 4552 4570
47. F. van Heesch, J. Prins, J.P. Konsman, K.G. Westphal, B. Olivier, A.D. Kraneveld, and S.M. Korte Lipopolysaccharide-induced anhedonia is abolished in male serotonin transporter knockout rats: an intracranial self-stimulation study Brain Behav. Immun. 29 2013 98 103
48. C.L. Raison, L. Capuron, and A.H. Miller Cytokines sing the blues: inflammation and the pathogenesis of depression Trends Immunol. 27 2006 24 31
49. M. Hinwood, R.J. Tynan, J.L. Charnley, S.B. Beynon, T.A. Day, and F.R. Walker Chronic stress induced remodeling of the prefrontal cortex: structural re-organization of microglia and the inhibitory effect of minocycline Cereb. Cortex 23 2013 1784 1797
50. A.M. Myint, B.E. Leonard, H.W. Steinbusch, and Y.K. Kim Th1, th2, and th3 cytokine alterations in major depression J. Affect. Disord. 88 2005 167 173
51. F.S. Dhabhar, H.M. Burke, E.S. Epel, S.H. Mellon, R. Rosser, V.I. Reus, and O.M. Wolkowitz Low serum il-10 concentrations and loss of regulatory association between il-6 and il-10 in adults with major depression J. Psychiatry Res. 43 2009 962 969
52. C. de Bodinat, B. Guardiola-Lemaitre, E. Mocaer, P. Renard, C. Munoz, and M.J. Millan Agomelatine, the first melatonergic antidepressant: discovery, characterization and development Nat. Rev. Drug Discov. 9 2010 628 642
53. D.G. Janssen, R.N. Caniato, J.C. Verster, and B.T. Baune A psychoneuroimmunological review on cytokines involved in antidepressant treatment response Hum. Psychopharmacol. 25 2010 201 215
54. N. Brunello, S. Alboni, G. Capone, C. Benatti, J.M. Blom, F. Tascedda, P. Kriwin, and J. Mendlewicz Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression Int. Clin. Psychopharmacol. 21 2006 219 225
55. O. Mutlu, E. Gumuslu, G. Ulak, I.K. Celikyurt, F. Akar, E. Bektas, T. Demirtas, H.M. Kir, M.M. Musul, and F. Erden Antidepressant-like activity of agomelatine in the mouse unpredictable chronic mild stress model Drug Dev. Res. 74 2013 203 215
56. L.N. Cates, A.J. Roberts, S. Huitron-Resendiz, and P.B. Hedlund Effects of lurasidone in behavioral models of depression: role of the 5-ht(7) receptor subtype Neuropharmacology 70 2013 211 217
57. A. Luoni, F. Macchi, M. Papp, R. Molteni, and M.A. Riva Lurasidone exerts antidepressant properties in the chronic mild stress model through the regulation of synaptic and neuroplastic mechanisms in the rat prefrontal cortex Int. J. Neuropsychopharmacol. 2014
58. R. Schwarcz, J.P. Bruno, P.J. Muchowski, and H.Q. Wu Kynurenines in the mammalian brain: when physiology meets pathology Nat. Rev. Neurosci. 13 2012 465 477
59. R. Dantzer, J.C. O'Connor, M.A. Lawson, and K.W. Kelley Inflammation-associated depression: from serotonin to kynurenine Psychoneuroendocrinology 36 2011 426 436
60. R. Molteni, F. Macchi, C. Zecchillo, M. Dell'agli, E. Colombo, F. Calabrese, G. Guidotti, G. Racagni, and M.A. Riva Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine Eur. Neuropsychopharmacol. 23 2013 1645 1655
61. R. Dantzer Cytokine, sickness behavior, and depression Immunol. Allergy Clin. North Am. 29 2009 247 264
62. J.C. Felger, and F.E. Lotrich Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications Neuroscience 246 2013 199 229
63. R. Uher, K.E. Tansey, K. Malki, and R.H. Perlis Biomarkers predicting treatment outcome in depression: what is clinically significant? Pharmacogenomics 13 2012 233 240
64. A. Cattaneo, M. Gennarelli, R. Uher, G. Breen, A. Farmer, K.J. Aitchison, I.W. Craig, C. Anacker, P.A. Zunsztain, P. McGuffin, and C.M. Pariante Candidate genes expression profile associated with antidepressants response in the gendep study: differentiating between baseline 'predictors' and longitudinal 'targets' Neuropsychopharmacology 38 2013 377 385